N, C., R, S., S, C., E, C., JG, M., & JB, B. (2012). Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British journal of haematology, 158(4), 539. https://doi.org/10.1111/j.1365-2141.2012.09184.x
Chicago Style (17th ed.) CitationN, Cooper, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, and Bussel JB. "Platelet-associated Antibodies, Cellular Immunity and FCGR3a Genotype Influence the Response to Rituximab in Immune Thrombocytopenia." British Journal of Haematology 158, no. 4 (2012): 539. https://doi.org/10.1111/j.1365-2141.2012.09184.x.
MLA (9th ed.) CitationN, Cooper, et al. "Platelet-associated Antibodies, Cellular Immunity and FCGR3a Genotype Influence the Response to Rituximab in Immune Thrombocytopenia." British Journal of Haematology, vol. 158, no. 4, 2012, p. 539, https://doi.org/10.1111/j.1365-2141.2012.09184.x.